With a new patent settlement, generic partners Mylan and Natco have cleared one hurdle to a potential U.S. launch of their generic to Novo Nordisk's wildly popular Type 2 diabetes drug Ozempic.

This leaflet answers some common questions about MODAFINIL MYLAN. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All ...

A clinical expert further explained that eye redness is not uncommon with latanoprost–netarsudil, but it is not usually uncomfortable and is reversible. While it can be intolerable for some people, ...

Purpose: We investigated the intraocular pressure (IOP) variations after switching from 0.005% latanoprost to 0.01% bimatoprost in open-angle glaucoma patients who experienced IOP elevation during ...

Mylan has become the first company to launch a generic version of GlaxoSmithKline's (GSK) big-selling respiratory drug Seretide in the UK. Seretide (salmeterol xinafoate/fluticasone propionate ...

NATCO Pharma Ltd on Monday announced that its partner Mylan Pharmaceuticals Inc has reached a patent litigation settlement with Novo Nordisk in the US over generic Ozempic, a drug used to lower ...